Bipartisan Senate Bill Would Require Insurers to Count Drug Coupons Toward Patient Deductibles
Stalled
No legislative action in over 90 days.
Small business owners who offer group health plans could see modest premium increases over time as insurers adjust pricing to account for faster deductible accumulation. However, small business owners or their employees who personally use specialty drugs would benefit from lower out-of-pocket costs. The net effect depends on individual circumstances.
Committee on Health, Education, Labor, and Pensions. Hearings held.
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Sent to a congressional committee for expert review. The committee decides whether this bill moves forward.
Introduced in Senate
The bill was officially filed and given a number. It now enters the legislative queue.
No votes have been recorded for this legislation yet.
Rep. Thomas H. Kean, Jr. (R-NJ) introduced the HELP Copays Act (H.R. 6423) to ensure that financial assistance, including manufacturer coupons and nonprofit grants, counts toward patient deductibles and out-of-pocket maximums, aiming to lower costs for those with chronic conditions.
Legal analysis in Law360 explores the regulatory scrutiny of copay adjustment programs, highlighting the HELP Copays Act as a primary legislative effort to mandate that third-party assistance applies to patient deductibles, potentially reshaping pharmaceutical payment litigation.
KFF details the mechanics of copay accumulators and maximizers, noting that the bipartisan HELP Copays Act would require health plans to count all forms of copay assistance toward enrollees' out-of-pocket limits, addressing a loophole that currently leaves patients with high surprise bills.
Document Type
Congressional Bill
Official Title
HELP Copays Act
Analysis generated by AI. Always verify with official sources.